Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression

Factors associated with Type I and Type II endometrial cancer

(2010) Ashley S. Felix et al.   CANCER CAUSES & CONTROL

High Levels of Expression of Human Stromal Cell-Derived Factor-1 Are Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

(2010) J. J. Liang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

Basal and Steroid Hormone-Regulated Expression of CXCR4 in Human Endometrium and Endometriosis

(2010) Abigail Ruiz et al.   Reproductive Sciences

Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma

(2009) Yuri Akishima-Fukasawa et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The Influence of Tumor-Host Interactions in the Stromal Cell-Derived Factor-1/CXCR4 Ligand/Receptor Axis in Determining Metastatic Risk in Breast Cancer

(2009) Saima Hassan et al.   AMERICAN JOURNAL OF PATHOLOGY

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis

(2009) Takayuki Kobayashi et al.   BREAST CANCER RESEARCH AND TREATMENT

Positive Feedback Activation of Estrogen Receptors by the CXCL12-CXCR4 Pathway

(2009) K. Sauve et al.   CANCER RESEARCH

The CXCR4/CXCL12 axis in endometrial cancer

(2009) Stefania Gelmini et al.   CLINICAL & EXPERIMENTAL METASTASIS

CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival

(2009) Valentina Mirisola et al.   EUROPEAN JOURNAL OF CANCER

Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence

(2009) Nabila Rasool et al.   GYNECOLOGIC ONCOLOGY

Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers

(2009) Jiro Fujimoto et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival

(2008) Ingeborg B. Engelsen et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY